Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2716-2722
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2716
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2716
Figure 1 Cellular growth inhibition of pyrrolidine dithiocarbamate alone or with Cisplatin on MKN45 cells.
PDTC: Pyrrolidine dithiocarbamate.
Figure 2 Expression of p65 and p53 isoforms in MKN45 cells.
A: Expression of p65 mRNA in MKN45 cells; B: Expression of p65 protein in MKN45 cells; C: Expression of Δ133p53 mRNA in MKN45 cells; D: Expression of p53β mRNA in MKN45 cells.
Figure 3 Correlation of p65 and p53 isoforms mRNA expression in MKN45 cells.
A: Correlation of p65 and Δ133p53 mRNA expression in MKN45 cells; r = 0.085, P < 0.01; B: Correlation of p65 and p53β mRNA expression in MKN45cells. r = 0.076, P > 0.05.
- Citation: Zhang HM, Sang XG, Wang YZ, Cui C, Zhang L, Ji WS. Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells. World J Gastroenterol 2017; 23(15): 2716-2722
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2716.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2716